Privia Health Group, Inc. (NASDAQ:PRVA) Receives $27.77 Consensus PT from Brokerages

Shares of Privia Health Group, Inc. (NASDAQ:PRVAGet Free Report) have been given an average recommendation of “Buy” by the thirteen ratings firms that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating on the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $27.77.

A number of equities analysts have recently issued reports on PRVA shares. Barclays upped their price target on Privia Health Group from $23.00 to $24.00 and gave the stock an “equal weight” rating in a research report on Tuesday, May 27th. Robert W. Baird upped their price target on shares of Privia Health Group from $24.00 to $26.00 and gave the company an “outperform” rating in a report on Tuesday, April 15th. JPMorgan Chase & Co. increased their target price on shares of Privia Health Group from $29.00 to $32.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 28th. Truist Financial upped their price target on shares of Privia Health Group from $27.00 to $28.00 and gave the stock a “buy” rating in a research report on Thursday, April 10th. Finally, Canaccord Genuity Group increased their price objective on shares of Privia Health Group from $29.00 to $30.00 and gave the company a “buy” rating in a report on Friday, February 28th.

View Our Latest Research Report on Privia Health Group

Insider Buying and Selling at Privia Health Group

In other news, Director Matthew Shawn Morris sold 10,309 shares of Privia Health Group stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $23.33, for a total value of $240,508.97. Following the sale, the director now owns 59,792 shares of the company’s stock, valued at $1,394,947.36. The trade was a 14.71% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Parth Mehrotra sold 13,773 shares of the business’s stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $24.99, for a total transaction of $344,187.27. Following the sale, the chief executive officer now directly owns 423,143 shares in the company, valued at approximately $10,574,343.57. This represents a 3.15% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 51,579 shares of company stock worth $1,226,367. 10.70% of the stock is owned by company insiders.

Institutional Trading of Privia Health Group

Several institutional investors and hedge funds have recently modified their holdings of the business. Rhumbline Advisers lifted its stake in shares of Privia Health Group by 1.3% during the fourth quarter. Rhumbline Advisers now owns 287,200 shares of the company’s stock valued at $5,615,000 after buying an additional 3,658 shares during the period. Barclays PLC boosted its stake in shares of Privia Health Group by 240.3% in the third quarter. Barclays PLC now owns 224,018 shares of the company’s stock valued at $4,079,000 after purchasing an additional 158,188 shares during the period. Choreo LLC boosted its stake in shares of Privia Health Group by 8.7% in the fourth quarter. Choreo LLC now owns 21,841 shares of the company’s stock valued at $425,000 after purchasing an additional 1,752 shares during the period. PNC Financial Services Group Inc. grew its holdings in Privia Health Group by 8.0% during the 4th quarter. PNC Financial Services Group Inc. now owns 7,169 shares of the company’s stock worth $140,000 after acquiring an additional 533 shares in the last quarter. Finally, Versor Investments LP acquired a new position in Privia Health Group during the 4th quarter worth $721,000. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Privia Health Group Stock Up 0.0%

Shares of NASDAQ:PRVA opened at $23.01 on Friday. The firm has a 50 day moving average of $23.42 and a 200 day moving average of $22.81. The company has a market capitalization of $2.81 billion, a price-to-earnings ratio of 230.12, a price-to-earnings-growth ratio of 3.47 and a beta of 0.83. Privia Health Group has a 52 week low of $16.37 and a 52 week high of $26.09.

About Privia Health Group

(Get Free Report

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

Featured Articles

Analyst Recommendations for Privia Health Group (NASDAQ:PRVA)

Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.